Ory EC

No ORCID on file · 1 paper in corpus
lab-animal 2022
Cancers ·doi:10.3390/cancers14030800

BACKGROUND: The development of chemoresistance to paclitaxel and carboplatin represents a major therapeutic challenge in ovarian cancer, a disease frequently characterized by malignant ascites and extrapelvic metastasis. Microtentacles (McT…